Technology Enhanced Adolescent Mental Health (TEAM)
Key facts
- Who runs it
- University of Notre Dame
- Where
- South Bend, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 6 Sept 2022
- Ended
- 15 Jan 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Non-invasive Transcutaneous Nerve Stimulation (tVNS)
- Record updated
- 17 August 2025
Who can take part
- Age
- 13 years to 17 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Have used alcohol
- Have engaged in ≥ 3 episodes of NSSI in the past 6 months or ≥ 5 lifetime (1 of these 5 must be in the past year)
- Own a smartphone (iPhone or Android)
Who cannot take part
- Have a cardiac pacemaker, implanted defibrillator, or implanted or metallic electronic device
- Have a history of seizures or epilepsy
- Temperomandibular Joint Disorder
- Autism
- Schizophrenia
- Pregnant or breastfeeding
- Bell's Palsy
- Impaired cranial nerve function or facial pain
Where in United States
- University of Notre DameSouth Bend, United States
About the trial
What the trial wants to find out
Adolescent nonsuicidal self-injury (NSSI) and alcohol misuse, alone and especially in combination, portend significant functional impairment in adulthood (e.g., relationship dysfunction, depression, suicidality). Although psychosocial interventions for NSSI and substance use are effective for some, they are also expensive and require highly trained clinicians. Treatment is therefore often unavailable to disadvantaged adolescents and those who live rurally. Thus, lower-cost alternative treatments are needed. We will evaluate the efficacy of noninvasive transcutaneous vagus nerve stimulation (tVNS), an effective treatment for depression, in reducing risk for NSSI and substance misuse among vulnerable adolescents.
The 2 groups in the trial
- Treatment GroupTreatment being tested
Participants will receive a tVNS device.
Treatment: Non-invasive Transcutaneous Nerve Stimulation (tVNS)
- Non-Treatment GroupTreatment being tested
Participants will not receive a tVNS device.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Leveraging Biomarkers and New Technologies to Reduce Self-Injury and Substance Abuse Risk Among Highly Vulnerable Adolescents
- Record updated
- 17 August 2025